Jump to content

List of adverse effects of lurasidone

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Lady Meg (talk | contribs) at 13:51, 10 August 2023 (Common: Just say it. It’s called Akathisia. Or add Akathisia. I get tired of the code words for these disorders from the medical community.). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

This is a list of adverse effects of the antipsychotic drug lurasidone, sorted by frequency of occurrence.[1][2][3]

Very common

Very common (>10% incidence) adverse effects include:

  • Somnolence (dose-dependent; produces an intermediate degree of sedation compared to other atypical antipsychotics[4])
  • Akathisia (dose-dependent)
  • Fasting glucose increased
  • Nausea
  • Parkinsonism

Common

Common (1–10% incidence) adverse effects include:

Uncommon

Uncommon (0.1–1% incidence) adverse effects include:

Rare

Rare (0.01–0.1% incidence) adverse effects include:

Unknown frequency

Unknown frequency adverse effects include:

References

  1. ^ Truven Health Analytics, Inc. DrugPoint System (Internet) [cited 2013 Oct 1]. Greenwood Village, CO: Thomsen Healthcare; 2013.
  2. ^ lurasidone (Rx) - Latuda [Internet]. Medscape Reference. [cited 2013 Oct 1]. Available from: http://reference.medscape.com/drug/latuda-lurasidone-999605#4
  3. ^ LATUDA (lurasidone hydrochloride) tablet, film coated [Bushu Pharmaceutical, LTD.] [Internet]. DailyMed. 2010 [cited 2013 Oct 1]. Available from: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=88a244d1-eddb-499c-bee2-e1f49056e78f
  4. ^ a b Leucht, S; Cipriani, A; Spineli, L; Mavridis, D; Orey, D; Richter, F; Samara, M; Barbui, C; Engel, RR; Geddes, JR; Kissling, W; Stapf, MP; Lässig, B; Salanti, G; Davis, JM (September 2013). "Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis". Lancet. 382 (9896): 951–962. doi:10.1016/S0140-6736(13)60733-3. PMID 23810019. S2CID 32085212.
  5. ^ Ketter, T. A; Sarma, K; Silva, R; Kroger, H; Cucchiaro, J; Loebel, A (2016-02-26). "LURASIDONE IN THE LONG‐TERM TREATMENT OF PATIENTS WITH BIPOLAR DISORDER: A 24‐WEEK OPEN‐LABEL EXTENSION STUDY". Depression and Anxiety. 33 (5): 424–434. doi:10.1002/da.22479. PMC 5069590. PMID 26918425.